Try our beta test site

Olaparib in Combination With Carboplatin for Refractory or Recurrent Women s Cancers

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )
ClinicalTrials.gov Identifier:
NCT01237067
First received: November 6, 2010
Last updated: February 22, 2017
Last verified: February 2, 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 3, 2017
  Primary Completion Date: November 16, 2014 (Final data collection date for primary outcome measure)